From Insight to Innovation: Integrating user preferences into Multipurpose Prevention Technology development

Friday17July

15:00 GMT

Virtual

How can women’s preferences help shape the future of multipurpose prevention technologies?

Join IMPT to explore emerging research on user experiences with an investigational vaginal film for HIV prevention and contraception and preferences for multipurpose vaginal rings. Together, these studies highlight the critical role of end-user perspectives in guiding MPT innovation.

Presentations:

End-user research findings from MATRIX-002 to inform MPT development: A multi-country study of a placebo vaginal film among reproductive-age women
Alexandra Minnis, PhD, MPH (RTI; UC Berkeley School of Public Health) and Nyaradzo Mgodi, MD (University of Zimbabwe Clinical Trials Research Centre)

Multipurpose vaginal rings: Preferences from a national discrete choice experiment survey among US women
Ann Gottert, PhD, MPH (Population Council)

Moderator: Bethany Young Holt, PhD, MPH (IMPT | CAMI Health)

Featured Resources

Document

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

These materials, developed by Zambia’s Ministry of Health, can be used to train clinicians and mobilisers in delivery of PrEP methods, including injectable lenacapavir (LEN), cabotegravir (CAB), the dapivirine vaginal ring (DVR), the Dual Prevention Pill (DPP), and oral PrEP.

Document

Zambia Guidelines for Pre and Post-Exposure Prophylaxis for HIV Infection, 2025

These clinical guidelines, developed by Zambia’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR), as well as the Dual Prevention Pill and oral PrEP.

Document

The Dual Prevention Pill Inspiration Guide

This Dual Prevention Pill (DPP) “inspiration guide,” developed by AVAC, is designed to equip implementers, health practitioners, public health advocates, and community leaders with the proven methods, insights, and creative strategies needed to effectively market and communicate the DPP to relevant audiences.

Document

The Dual Prevention Pill: A catalyst for integrated HIV and family planning services in Zambia: A policy brief

This policy brief, developed by Copper Rose Zambia and AVAC, presents findings from assessments conducted at seven public health facilities, three community hubs, and five pharmacies which reveal readiness and willingness to deliver the Dual Prevention Pill across various service delivery platforms, especially in community settings.

External Link

A Dual Prevention Pill for HIV & Pregnancy Prevention: A pilot study among adolescent girls and young women in Zimbabwe

This article from AIDS and Behavior describes the results of a study examining whether an over-encapsulated dual prevention pill (DPP) combining PrEP + oral contraceptive would be preferred, acceptable, and improve adherence compared to PrEP alone amongst adolescent girls and young women in Zimbabwe.

External Link

2025 State of Self-Care Report: Self-Care in a changing world

This report from the Self-Care Trailblazer Group provides an update on the state of sexual and reproductive health self-care policy, practice, and evidence that can be used as a resource to strengthen self-care implementation and advocacy. It includes a case study on the Dual Prevention Pill, “Community-Centered Perspectives on the Dual Prevention Pill as a…

External Link

“…this could be a noble idea and a game changer.” The Potential of a Dual Prevention Pill for HIV and Pregnancy Prevention among Adolescent Girls and Young Women in Zimbabwe

This article from PLOS Global Public Health describes the opinions of adolescent girls and young women and health care providers in Zimbabwe regarding the dual prevention pill (DPP), combining oral contraceptives with oral PrEP to simultaneously prevent unintended pregnancy and HIV.

External Link

Multipurpose Prevention Technologies for the Prevention of Unintended Pregnancy, HIV, and Other Sexually Transmitted Infections: Regulatory pathways and challenges

This article from Frontiers in Reproductive Health discusses potential regulatory pathways for multipurpose prevention technologies (MPTs).

Document

Frequently Asked Questions about the Dual Prevention Pill

This factsheet provides answers to the most frequently asked questions about the Dual Prevention Pill (DPP), including what it is, who might use it, and how it can be rolled out.

Document

Developing and Introducing a Dual Prevention Pill- Oral PrEP & oral contraception for HIV and pregnancy prevention

A coalition of partners is developing a novel Dual Prevention Pill (DPP) for prevention of pregnancy and HIV acquisition in high-need countries. In East and Southern Africa — where the DPP is initially planned for introduction — 65 percent of new HIV infections are amongst women aged 15 and over, and 15 percent of women…